CIBC Issues Positive Forecast for NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Stock Price

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) had its target price lifted by investment analysts at CIBC from C$5.50 to C$5.75 in a report released on Thursday,BayStreet.CA reports. CIBC’s price target suggests a potential upside of 3.79% from the stock’s previous close.

Separately, Scotiabank boosted their price objective on NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a research note on Thursday. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of C$6.13.

NorthWest Health Prop Real Est Inv Trust Price Performance

Shares of NWH.UN traded down C$0.18 on Thursday, hitting C$5.54. The company’s stock had a trading volume of 887,343 shares, compared to its average volume of 597,925. The company has a market capitalization of C$1.38 billion, a PE ratio of -13.22, a PEG ratio of 0.74 and a beta of 1.46. NorthWest Health Prop Real Est Inv Trust has a fifty-two week low of C$4.33 and a fifty-two week high of C$5.73. The company has a 50 day moving average price of C$5.10 and a 200 day moving average price of C$4.96. The company has a debt-to-equity ratio of 129.42, a current ratio of 0.25 and a quick ratio of 0.06.

NorthWest Health Prop Real Est Inv Trust Company Profile

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.